1. Viremia does not independently predict cardiovascular disease in people with HIV: a RESPOND cohort study. Elvstam O, Ryom L, Neesgaard B, Tau L, Günthard H F, Zangerle R, Vehreschild J J, Wit F, Sönnerborg A, Kovari H, Abutidze A, Petoumenos K, Jaschinski J, Hosein S, Bogner J, Grabmeier-Pfistershammer K, Garges H, Rooney J, Young L, Law M, Kirk O for the RESPOND Study Group.
   Open Forum Infectious Diseases 2025. Jan 13;12(2):ofaf016. 
   Abstract
    

2. A simple tool to evaluate the effectiveness of HIV care for settings with gaps in data availability  (ESTIHIV). Raben D, Jakobsen M L, Trajanovska J, Kowalska J, Vassilenko A, Dragas S, Harxhi A, Dragovic G J, Jaschinski N, Neesgaard B, Hjorth-Larsen K, Garges H, Gallant J, Lundgren J D, Philips A, Cambiano V, Yazdanpanah Y and Mocroft A. 
   PLOS One 2025. Jan 29;20(1):e0316794.
    Abstract
    

3. Incident tuberculosis in people with HIV across Europe from 2012-2022: incidence rates, risk factors, and regional differences in a multicentre cohort study​. Kraef C, Roen A, Podlekareva D, Bakowska E, Nemeth J, Knappik M, Payen M-C, Wit F, Mussini C, d’Arminio Monforte11 A, Castagna A, Chkhartishvili N, Neesgaard B, Jaschinski1 N, Volny Anne A, Borodulina E, Ballief M, Wallner E, Israelski D, Garges H, Mocroft A, Kirk O and the RESPOND Study Group. 
   European Respiratory Journal 2025. Feb 20:2401904. 
   Abstract
    

Total Publications January 2025: 346